Close Menu

NEW YORK (GenomeWeb) – A team led by researchers at the Wellcome Sanger Institute has used genome-scale CRISPR screening to create a new resource of cancer dependencies and develop a framework to prioritize existing cancer drug targets and suggest new ones.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.